Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Costa Rica has been steadily increasing over the years, driven by various factors such as government initiatives, rising awareness of preventable diseases, and a growing population.
Customer preferences: Costa Rican customers have shown a preference for vaccines that offer protection against common infectious diseases such as measles, mumps, and rubella. There has also been an increase in demand for vaccines that provide protection against diseases that are prevalent in the country such as dengue fever and hepatitis A. Customers are more likely to choose vaccines that are affordable, effective, and have minimal side effects.
Trends in the market: One of the major trends in the vaccines market in Costa Rica is the increasing number of government initiatives aimed at promoting vaccination. The government has implemented various programs to increase the availability and accessibility of vaccines, particularly in rural areas. There has also been an increase in the number of private healthcare providers offering vaccination services. Additionally, there has been a growing trend towards the use of combination vaccines, which offer protection against multiple diseases in a single shot.
Local special circumstances: Costa Rica has a well-established healthcare system, which is accessible to all citizens and residents. The country has a high literacy rate, which has contributed to the growing awareness of the importance of vaccination in preventing diseases. The country also has a large expatriate population, which has contributed to the demand for vaccines that offer protection against diseases that are prevalent in other parts of the world.
Underlying macroeconomic factors: The Costa Rican economy has been growing steadily over the years, which has contributed to the increasing demand for vaccines. The country has a relatively young population, which has contributed to the growing demand for pediatric vaccines. Additionally, the country has a high level of urbanization, which has led to an increase in the spread of communicable diseases. The government has recognized the importance of vaccination in preventing the spread of diseases, and has therefore implemented various initiatives to promote vaccination.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
